CTOs on the Move

Forest Laboratories

www.frx.com

 
Forest Laboratories is a pharmaceutical company headquartered in New York City, US. The company's research and development spending has grown rapidly in recent years and as of 2007, approached almost a billion US dollars a year, which put it on the list of the top 100 global corporations in R&D spending. Forest Laboratories is also known for licensing European pharmaceuticals for sale in the United States.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.frx.com
  • 909 3rd Ave
    New York, NY USA 10022
  • Phone: 212.421.7850

Executives

Name Title Contact Details

Similar Companies

Exeltis

We create solutions for Women´s Health and other priority such as Respiratory, Dermatology and Endocrinology. Excellence and innovation.

Arizona Nutritional Supplements

Arizona Nutritional Supplements is a Chandler, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CRC Consulting

CRC Consulting is a Roslindale, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry in the United States. Its lead product candidate, omadacycline, is a tetracycline-derived and broad-spectrum antibiotic developed in oral tablet and intravenous formulations for use as a monotherapy antibiotic for acute bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), urinary tract infections, and other serious community-acquired bacterial infections. The company has special protocol assessment agreements with Food and Drug Administration for the Phase III trials planned in ABSSSI and CABP. It is also developing sarecycline, a tetracycline-derived compound that is in Phase III clinical trials for use in the treatment of acne and rosacea. The company has collaborative research and license agreement with Actavis to research, develop, and commercialize tetracycline products; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and collaboration agreement with Purdue Pharmaceuticals L.P. to commercialize Intermezzo. Paratek Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

Mera Pharmaceuticals

Mera Pharmaceuticals is a Kailua Kona, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.